Cutler Group LP Cure Vac N.V. Put Options Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Oct 25, 2022	SELL	$7.48 - $15.24 $2,244 - $4,572	-300 Reduced 37.5%	500 $22,000
Q2 2022 Aug 04, 2022	BUY	$13.18 - $19.41 $1,318 - $1,941	100 Added 14.29%	800 $42,000
Q1 2022 Apr 14, 2022	SELL	$14.73 - $35.25 $297,546 - $712,050	-20,200 Reduced 96.65%	700 $35,000
Q4 2021 Jan 18, 2022	BUY	$33.72 - $48.22 $229,296 - $327,896	6,800 Added 48.23%	20,900 $132,000
Q3 2021 Oct 26, 2021	SELL	$49.26 - $74.5 $1.13 Million - $1.71 Million	-22,900 Reduced 61.89%	14,100 $222,000
Q2 2021 Jul 19, 2021	BUY	$56.91 - $127.53 $1.13 Million - $2.54 Million	19,900 Added 116.37%	37,000 $479,000
Q1 2021 Apr 26, 2021	SELL	$79.79 - $126.29 $2.24 Million - $3.55 Million	-28,100 Reduced 62.17%	17,100 $319,000
Q4 2020 Jan 21, 2021	BUY	$46.76 - $136.27 $331,996 - $967,517	7,100 Added 18.64%	45,200 $1.18 Million
Q3 2020 Oct 27, 2020	BUY	$43.8 - $77.2 $1.67 Million - $2.94 Million	38,100 New	38,100 $722,000

10.5M

75.5K

33.5K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $615M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.